Bank of New York Mellon’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-32,759
| Closed | -$160K | – | 4154 |
|
|
2025
Q1 | $160K | Buy |
32,759
+3,686
| +13% | +$22.2K | ﹤0.01% | 3934 |
|
|
2024
Q4 | $242K | Buy |
29,073
+122
| +0.4% | +$1.07K | ﹤0.01% | 3879 |
|
|
2024
Q3 | $301K | Sell |
28,951
-5,337
| -16% | -$88.7K | ﹤0.01% | 3760 |
|
|
2024
Q2 | $675K | Buy |
34,288
+5,579
| +19% | +$112K | ﹤0.01% | 3407 |
|
|
2024
Q1 | $735K | Buy |
28,709
+7,697
| +37% | +$197K | ﹤0.01% | 3314 |
|
|
2023
Q4 | $580K | Buy |
21,012
+439
| +2% | +$26.8K | ﹤0.01% | 3474 |
|
|
2023
Q3 | $1.25M | Buy |
20,573
+302
| +1% | +$21.2K | ﹤0.01% | 3042 |
|
|
2023
Q2 | $1.33M | Buy |
20,271
+342
| +2% | +$25K | ﹤0.01% | 3053 |
|
|
2023
Q1 | $1.27M | Buy |
19,929
+2,538
| +15% | +$290K | ﹤0.01% | 3038 |
|
|
2022
Q4 | $2.41M | Buy |
17,391
+1,216
| +8% | +$171K | ﹤0.01% | 2748 |
|
|
2022
Q3 | $2.05M | Buy |
16,175
+1,279
| +9% | +$145K | ﹤0.01% | 2838 |
|
|
2022
Q2 | $1.23M | Buy |
14,896
+1,251
| +9% | +$97K | ﹤0.01% | 3108 |
|
|
2022
Q1 | $1.32M | Buy |
13,645
+148
| +1% | +$19.5K | ﹤0.01% | 3140 |
|
|
2021
Q4 | $2.7M | Sell |
13,497
-12,246
| -48% | -$2.89M | ﹤0.01% | 2809 |
|
|
2021
Q3 | $6.37M | Buy |
25,743
+1,428
| +6% | +$408K | ﹤0.01% | 2370 |
|
|
2021
Q2 | $10.1M | Buy |
24,315
+7,064
| +41% | +$2.8M | ﹤0.01% | 2130 |
|
|
2021
Q1 | $6.74M | Sell |
17,251
-1,482
| -8% | -$730K | ﹤0.01% | 2302 |
|
|
2020
Q4 | $10.5M | Sell |
18,733
-345
| -2% | -$219K | ﹤0.01% | 1980 |
|
|
2020
Q3 | $13.3M | Sell |
19,078
-317
| -2% | -$247K | ﹤0.01% | 1700 |
|
|
2020
Q2 | $15.3M | Buy |
19,395
+3,957
| +26% | +$2.98M | ﹤0.01% | 1604 |
|
|
2020
Q1 | $9.19M | Sell |
15,438
-536
| -3% | -$522K | ﹤0.01% | 1747 |
|
|
2019
Q4 | $18.2M | Sell |
15,974
-282
| -2% | -$307K | ﹤0.01% | 1628 |
|
|
2019
Q3 | $19.3M | Buy |
16,256
+297
| +2% | +$454K | 0.01% | 1548 |
|
|
2019
Q2 | $26.3M | Sell |
15,959
-597
| -4% | -$1.03M | 0.01% | 1389 |
|
|
2019
Q1 | $33.7M | Sell |
16,556
-849
| -5% | -$1.49M | 0.01% | 1235 |
|
|
2018
Q4 | $22.4M | Sell |
17,405
-27,502
| -61% | -$42.2M | 0.01% | 1399 |
|
|
2018
Q3 | $84.9M | Buy |
44,907
+20,773
| +86% | +$42.9M | 0.02% | 695 |
|
|
2018
Q2 | $49.1M | Sell |
24,134
-3,551
| -13% | -$8.09M | 0.01% | 1028 |
|
|
2018
Q1 | $61.2M | Buy |
27,685
+2,483
| +10% | +$6.32M | 0.02% | 866 |
|
|
2017
Q4 | $58.1M | Buy |
25,202
+6,245
| +33% | +$12.7M | 0.02% | 923 |
|
|
2017
Q3 | $33.7M | Buy |
18,957
+1,347
| +8% | +$1.88M | 0.01% | 1226 |
|
|
2017
Q2 | $24M | Sell |
17,610
-43
| -0.2% | -$51.9K | 0.01% | 1437 |
|
|
2017
Q1 | $20.8M | Buy |
17,653
+1,699
| +11% | +$1.73M | 0.01% | 1525 |
|
|
2016
Q4 | $12.8M | Buy |
15,954
+902
| +6% | +$716K | ﹤0.01% | 1829 |
|
|
2016
Q3 | $13.2M | Buy |
15,052
+2,143
| +17% | +$1.55M | ﹤0.01% | 1716 |
|
|
2016
Q2 | $7.24M | Buy |
12,909
+1,008
| +8% | +$571K | ﹤0.01% | 2021 |
|
|
2016
Q1 | $6.55M | Buy |
11,901
+378
| +3% | +$232K | ﹤0.01% | 2049 |
|
|
2015
Q4 | $9.59M | Sell |
11,523
-654
| -5% | -$653K | ﹤0.01% | 1863 |
|
|
2015
Q3 | $13.5M | Sell |
12,177
-340
| -3% | -$620K | ﹤0.01% | 1684 |
|
|
2015
Q2 | $27.3M | Sell |
12,517
-116
| -0.9% | -$236K | 0.01% | 1260 |
|
|
2015
Q1 | $19.8M | Buy |
12,633
+2,753
| +28% | +$3.63M | 0.01% | 1503 |
|
|
2014
Q4 | $11.7M | Buy |
9,880
+1,317
| +15% | +$880K | ﹤0.01% | 1819 |
|
|
2014
Q3 | $3.98M | Buy |
8,563
+2,637
| +44% | +$1.22M | ﹤0.01% | 2451 |
|
|
2014
Q2 | $2.96M | Buy |
5,926
+3,555
| +150% | +$1.14M | ﹤0.01% | 2658 |
|
|
2014
Q1 | $698K | Buy |
2,371
+214
| +10% | +$64.8K | ﹤0.01% | 3454 |
|
|
2013
Q4 | $586K | Buy |
2,157
+810
| +60% | +$226K | ﹤0.01% | 3520 |
|
|
2013
Q3 | $470K | Buy |
+1,347
| New | +$500K | ﹤0.01% | 3547 |
|
Other funds holding BLUE
Bank of New York Mellon's BLUE Position: Q2 2025 in Review
Bank of New York Mellon sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 32,759 shares — an estimated $160K sold.
Bank of New York Mellon first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $84.9M in Q3 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Bank of New York Mellon reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Bank of New York Mellon sold 32,759 bluebird bio shares in Q2 2025, an estimated $160K.
- Bank of New York Mellon first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
- Bank of New York Mellon's bluebird bio position peaked at $84.9M in Q3 2018.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Bank of New York Mellon's 13F filing for Q2 2025, filed 5 Aug 2025.